Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cell-based Assays Market, by Application
1.4.2 Europe Cell-based Assays Market, by End User
1.4.3 Europe Cell-based Assays Market, by Products & Services
1.4.4 Europe Cell-based Assays Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2021, Jun) Leading Players
Chapter 4. Europe Cell-based Assays Market by Application
4.1 Europe Drug Discovery Market by Country
4.2 Europe Basic Research Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Cell-based Assays Market by End-use
5.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
5.2 Europe Academic & Research Institutes Market by Country
5.3 Europe Contract Research Organizations (CROs) Market by Country
Chapter 6. Europe Cell-based Assays Market by Products & Services
6.1 Europe Assay Kits Market by Country
6.2 Europe Reagents Market by Country
6.3 Europe Microplates Market by Country
6.4 Europe Probes & Labels Market by Country
6.5 Europe Instruments & Software Market by Country
6.6 Europe Cell Lines Market by Country
Chapter 7. Europe Cell-based Assays Market by Country
7.1 Germany Cell-based Assays Market
7.1.1 Germany Cell-based Assays Market by Application
7.1.2 Germany Cell-based Assays Market by End-use
7.1.3 Germany Cell-based Assays Market by Products & Services
7.2 UK Cell-based Assays Market
7.2.1 UK Cell-based Assays Market by Application
7.2.2 UK Cell-based Assays Market by End-use
7.2.3 UK Cell-based Assays Market by Products & Services
7.3 France Cell-based Assays Market
7.3.1 France Cell-based Assays Market by Application
7.3.2 France Cell-based Assays Market by End-use
7.3.3 France Cell-based Assays Market by Products & Services
7.4 Russia Cell-based Assays Market
7.4.1 Russia Cell-based Assays Market by Application
7.4.2 Russia Cell-based Assays Market by End-use
7.4.3 Russia Cell-based Assays Market by Products & Services
7.5 Spain Cell-based Assays Market
7.5.1 Spain Cell-based Assays Market by Application
7.5.2 Spain Cell-based Assays Market by End-use
7.5.3 Spain Cell-based Assays Market by Products & Services
7.6 Italy Cell-based Assays Market
7.6.1 Italy Cell-based Assays Market by Application
7.6.2 Italy Cell-based Assays Market by End-use
7.6.3 Italy Cell-based Assays Market by Products & Services
7.7 Rest of Europe Cell-based Assays Market
7.7.1 Rest of Europe Cell-based Assays Market by Application
7.7.2 Rest of Europe Cell-based Assays Market by End-use
7.7.3 Rest of Europe Cell-based Assays Market by Products & Services
Chapter 8. Company Profiles
8.1 Becton, Dickinson and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Acquisition and Mergers:
8.2.5.4 Approvals and Trials:
8.3 Thermo Fisher Scientific, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Geographical Expansions:
8.4 Bio-Rad laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Partnerships, Collaborations, and Agreements:
8.5.4.2 Acquisition and Mergers:
8.6 Danaher Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.7 Merck Group
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Lonza Group AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Corning Incorporated
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.10. Promega Corporation
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
8.10.2.2 Product Launches and Product Expansions:
Unique Offerings 